RegenSelect · Conditions · Tennis Elbow

Stem Cell Therapy for Tennis Elbow

Who qualifies, what the evidence actually shows, and how to find a verified orthopedic provider.

Tennis elbow — lateral epicondylitis — is one of the most common upper extremity overuse injuries, affecting both athletes and people who have never picked up a racket. It develops from repetitive stress to the common extensor tendon where it attaches to the lateral epicondyle of the elbow.

Among regenerative medicine indications, tennis elbow has some of the strongest randomized trial evidence supporting PRP. This page presents what the research actually shows — including the head-to-head data versus cortisone that most clinic websites leave out.

Who is a candidate

Chronic Lateral Epicondylitis

The primary indication. Cases lasting 3+ months that have failed conservative treatment — rest, NSAIDs, physical therapy, or cortisone injections — are the strongest candidates.

Tendon Degeneration (Tendinosis)

Degenerative changes in the common extensor tendon without active inflammation. Often seen on MRI or ultrasound as tendon thickening or partial tears at the lateral epicondyle.

Partial Extensor Tendon Tears

Small partial tears at the tendon attachment are a common finding in chronic tennis elbow. Regenerative therapy targets tendon healing rather than mechanical repair.

Post-Cortisone Failures

Patients who had temporary relief from cortisone injections but relapsed are frequently referred for PRP or BMAC. Cortisone can weaken tendons over time; regenerative therapy works differently.

What the evidence shows

Tennis elbow is one of the best-studied indications for PRP. The evidence here is more consistent than for most other orthopedic conditions.

PRP vs. cortisone at 6–12 months

Multiple randomized controlled trials show PRP outperforms cortisone injection at 6 and 12 months for chronic lateral epicondylitis. Short-term cortisone results look better, long-term PRP wins.

PRP superior

Clinic-reported improvement rates

Provider outcome studies consistently report 75–85% patient-reported improvement for chronic tennis elbow treated with PRP or BMAC.

75–85%

Strongest evidence among indications

Tennis elbow has more RCT support for PRP than most other orthopedic indications. The evidence base is stronger here than for knee OA or rotator cuff.

High

Typical recovery timeline

Most patients see meaningful improvement at 6–8 weeks. Full tendon remodeling continues for up to 6 months post-procedure.

6–12 weeks

What it costs

PRP injections for tennis elbow typically run $1,000–$3,500. BMAC procedures are higher, typically $3,000–$6,000. Cash-pay only — insurance does not cover regenerative therapy for lateral epicondylitis. Some providers offer multiple-injection packages at a reduced per-treatment rate.

Tennis elbow treatment is generally less expensive than knee or hip procedures because the injection volume and procedure complexity are lower. Ask for an itemized cost breakdown before committing.

Questions to ask before you book

1.

Are you using PRP, BMAC, or another biological product — and why for my case specifically?

2.

Is the injection image-guided with ultrasound? (It should be for accurate tendon placement.)

3.

How many treatments do you typically recommend for lateral epicondylitis?

4.

What rehabilitation protocol do you use after the injection?

5.

Do you have outcome data for tennis elbow patients specifically?

Find a verified elbow specialist

Every provider in the RegenSelect directory has been verified to offer regenerative medicine with an orthopedic focus. Filter by condition to find elbow specialists near you.

Browse Elbow Specialists →How we verify providersIs it worth the cost? →